Scholar Rock Holding SRRK
NASDAQ SRRK
$46.81 +0.65 (+1.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scholar Rock Holding (SRRK) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Scholar Rock Holding (SRRK) reported Return on Capital Employed [ROCE] of -88.89% for Q2 2026, up 11.10 percentage points from -99.99% a year earlier and up 10.98 percentage points from the prior quarter.

Analysis

Scholar Rock Holding (SRRK) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Scholar Rock Holding posted Return on Capital Employed [ROCE] of -100.12%, down 27.28 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -65.34 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -72.84% in FY2024 (-16.09 pp), -56.75% in FY2023 (-11.18 pp), -45.56% in FY2022 (+0.50 pp) and -46.06% in FY2021 (-11.28 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • Year over year, Return on Capital Employed [ROCE] gained in three of the last eight quarters, with an average year-over-year change of -12.90 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2025 (a gain of 25.66 percentage points); the low point was Q3 2024 (a drop of 73.11 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -99.87% (Q1 2026), -109.10% (Q4 2025) and -115.35% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Scholar Rock Holding 5.69 Bn 5.69 Bn - -88.89%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -88.89%
Mar 31, 2026 -99.87%
Dec 31, 2025 -109.10%
Sep 30, 2025 -115.35%
Jun 30, 2025 -99.99%
Mar 31, 2025 -67.07%
Dec 31, 2024 -89.99%
Sep 30, 2024 -141.01%
Jun 30, 2024 -97.91%
Mar 31, 2024 -75.18%
Dec 31, 2023 -69.04%
Sep 30, 2023 -67.90%
Jun 30, 2023 -59.48%
Mar 31, 2023 -54.13%
Dec 31, 2022 -39.77%
Sep 30, 2022 -34.62%
Jun 30, 2022 -40.19%
Mar 31, 2022 -43.54%
Dec 31, 2021 -54.79%
Sep 30, 2021 -48.15%
API Access

Scholar Rock Holding Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SRRK&period=max&api_key=YOUR_API_KEY